Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Income from Continuing Operations (2024 - 2025)

Historic Income from Continuing Operations for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to -$14.2 million.

  • Beta Bionics' Income from Continuing Operations fell 3998.62% to -$14.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$59.4 million, marking a year-over-year change of. This contributed to the annual value of -$41.3 million for FY2024, which is 2133.36% down from last year.
  • Beta Bionics' Income from Continuing Operations amounted to -$14.2 million in Q3 2025, which was down 3998.62% from -$16.9 million recorded in Q2 2025.
  • Over the past 5 years, Beta Bionics' Income from Continuing Operations peaked at -$8.3 million during Q1 2024, and registered a low of -$16.9 million during Q2 2025.